What are the contraindications for baclofen (GABA receptor agonist)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Baclofen Contraindications

The only absolute contraindication to baclofen is hypersensitivity to the drug itself. 1

Absolute Contraindication

  • Hypersensitivity to baclofen is the sole FDA-labeled absolute contraindication 1
  • True allergic reactions to baclofen are rare, and some patients with adverse reactions to oral baclofen may be mistakenly classified as allergic when they could potentially tolerate intrathecal formulations 2
  • Active infection is an absolute contraindication specifically for intrathecal baclofen therapy 2

Relative Contraindications and High-Risk Situations

Seizure Disorders

  • Baclofen may potentiate seizures in certain populations, particularly young children with cerebral palsy 3
  • In one pediatric series, 14% of children developed new-onset seizures after starting oral baclofen 3
  • While not an absolute contraindication, seizure history should be thoroughly discussed before initiating therapy, especially for intrathecal administration 2

Hepatic and Renal Dysfunction

  • Patients with hepatic or renal dysfunction require careful consideration, as these conditions affect drug clearance and increase risk of adverse effects 4
  • Elderly patients are at higher risk for sedative and hypotensive effects and require cautious dosing 4

Perioperative Considerations

  • Baclofen should never be abruptly discontinued perioperatively due to life-threatening withdrawal risks 4
  • Continue baclofen preoperatively including on the day of surgery 4
  • Abrupt withdrawal of intrathecal baclofen can cause high fever, altered mental status, rebound spasticity, muscle rigidity leading to rhabdomyolysis, multiorgan failure, and death 4
  • Oral baclofen withdrawal produces visual and auditory hallucinations, anxiety, agitation, delirium, fever, tremors, tachycardia, and seizures 4

Psychosocial Factors (Intrathecal Baclofen)

  • Unrealistic treatment goals 2
  • Unmanageable mental health issues 2
  • Psychosocial factors affecting compliance 2
  • Financial burden that would prevent ongoing therapy 2

Special Anatomical Considerations (Intrathecal Baclofen)

  • Vascular shunting for hydrocephalus is not a contraindication but may affect cerebrospinal fluid flow and requires discussion 2
  • Prior abdominal or pelvic surgery should be evaluated before proceeding to intrathecal therapy 2

Critical Safety Warnings

Drug Interactions

  • Tizanidine (a related GABA agonist) is absolutely contraindicated with ciprofloxacin and fluvoxamine due to severe drug interactions 4
  • Baclofen increases sedation risk when combined with opioids or other CNS depressants 4

Stroke Patients

  • Oral baclofen may cause significant sedation and has less impact on spasticity in stroke patients compared to other conditions 4
  • Diazepam (another GABA agonist) is relatively contraindicated in stroke patients during the recovery period 4

Common Pitfalls to Avoid

  • Do not mistake adverse reactions to oral baclofen for true allergy without proper evaluation 2
  • Never discontinue baclofen abruptly in long-term users—this is potentially fatal 4, 5
  • Do not use baclofen as first-line therapy without considering the significant CNS side effects (drowsiness, dizziness, sedation) 4
  • Recognize that cognitive impairment is not a contraindication; baclofen may actually be preferred in cognitively impaired patients as it controls spasticity without the cognitive side effects of some oral medications 2

References

Research

Best Practices for Intrathecal Baclofen Therapy: Patient Selection.

Neuromodulation : journal of the International Neuromodulation Society, 2016

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.